Dow Up0.36% Nasdaq Up0.42%

SciClone Pharmaceuticals, Inc. (SCLN)

-NasdaqGS
7.18 Up 0.13(1.81%) 10:29AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 127,058   156,269   132,565  
Cost of Revenue17,668  21,996  19,409  
Gross Profit 109,390   134,273   113,156  
Operating Expenses
Research Development7,463  5,145  12,346  
Selling General and Administrative90,317  76,249  69,390  
Non Recurring1,181  43,824   -  
Others -  2,645  2,465  
Total Operating Expenses -  127,863   -  
Operating Income or Loss 10,429   6,410   28,955  
Income from Continuing Operations
Total Other Income/Expenses Net2,880  47  50  
Earnings Before Interest And Taxes13,309  6,457  29,005  
Interest Expense103  185  213  
Income Before Tax13,206  6,272  28,792  
Income Tax Expense2,242  (3,348)670  
Minority Interest -   -   -  
Net Income From Continuing Ops10,964  9,620  28,122  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 10,964   9,620   28,122  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 10,964   9,620   28,122  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.